Editorial Board Members' Collection Series: Antibiotic Resistance Mechanisms and Molecular Epidemiology of ESKAPEE

Dear Colleagues,

In an era of rapidly evolving medical science and advanced healthcare, the emergence and spread of antibiotic resistance pose a significant threat to global public health. Some of the most notorious pathogens contributing to this crisis are ESKAPEE pathogens, which include Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species, and Escherichia coli. These bacteria have a remarkable ability to "escape" the effects of antibiotics and are the leading cause of severe life-threatening hospital/community-acquired infections that are often difficult to treat. The nature to develop multi-drug resistance and the ability to acquire genes that encode resistance, combined with the propensity to form complex microbial communities named biofilms, make ESKAPEE pathogens even more recalcitrant to treatments and host immune defenses. Understanding the molecular mechanisms that underly antibiotic resistance in ESKAPEE pathogens, at both the planktonic and sessile state, is crucial for developing effective therapeutic strategies and preventing the further spread of resistance, as well as to guide antibiotic treatment decisions. The aim of the Editorial Board Members’ Collection, “Antibiotic Resistance Mechanisms and Molecular Epidemiology of ESKAPEE”, is dedicated to collecting papers that expore the genetic and molecular factors that enable ESKAPEE pathogens to resist antibiotics and the epidemiology of their transmission. We also welcome cutting-edge research and innovative approaches centered around the ongoing battle against antibiotic resistance and biofilm-associated chronic infections in ESKAPEE bacteria.

Dr. Anabela Borges
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• ESKAPEE
• ESKAPE
• antibiotic resistance
• antibiotic resistance mechanisms
• molecular epidemiology